Previously, we have the beneficial effect of Aspirin in reducing in the death among colorectal cancer patients. Now, a prospective, observational study published in the March issue of the Journal of Clinical Oncology suggested that aspirin can also lower the risk of distant recurrence and breast cancer death. 
The results come from the study of 4,164 female registered nurses in the Nurses’ health Study who were diagnosed with stages I, II, or III breast cancer between 1976 and 2002. They were observed until death or June 2006.
At the end of the study, the investigators found that daily use of aspirin per week was associated with a 9% reduction in the risk of breast cancer death, 2 to 5 days per week use of aspirin was associated with a 60% reduction and 6 to 7 days per week use of aspirin was associated with 43% reduction in the risk of breast cancer death.
The association did not differ by stage, menopausal status, body mass index, or estrogen receptor status.
The investigators concluded that among women living at least 1 year after a breast cancer diagnosis can have their risk of distant recurrence and breast cancer death reduced by taking aspirin.
J Clin. Oncol 28; 1467-1472
Please visit us at healthreason.com
